Roivant Sciences (ROIV) Shares Issued (2022 - 2025)
Roivant Sciences (ROIV) posted Shares Issued of $135.6 million for Q2 2025, down 2.74% on a QoQ basis from $139.4 million in Q1 2025, and up 261.02% year-over-year from $37.6 million in Q2 2024.
Roivant Sciences (ROIV) Shares Issued (2022 - 2025) Analysis & Trends
Roivant Sciences' Shares Issued history runs 4 years deep, the most recent figure standing at $135.6 million for Q2 2025.
- Quarterly Shares Issued rose 261.02% year-over-year to $135.6 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $135.6 million (up 261.02% YoY) and the FY2025 annual result came in at $139.4 million, down 5.21% from the prior year.
- Shares Issued was $135.6 million for Q2 2025 at Roivant Sciences, down from $139.4 million in the prior quarter.
- Across five years, Shares Issued topped out at $154.6 million in Q4 2022 and bottomed at $37.6 million in Q2 2024.
- A 4-year average of $111.1 million and a median of $135.6 million in 2025 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued sank 75.46% — and 2025, when it jumped 261.02%.
- Roivant Sciences' Shares Issued stood at $154.6 million in 2022, then slumped by 40.72% to $91.7 million in 2023, then increased by 17.24% to $107.5 million in 2024, then increased by 26.16% to $135.6 million in 2025.
- Business Quant data shows ROIV's Shares Issued at $135.6 million in Q2 2025, $139.4 million in Q1 2025, and $107.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 135.59 Mn |
| Jun 30, 2025 | 135.59 Mn |
| Mar 31, 2025 | 139.41 Mn |
| Mar 31, 2025 | 139.41 Mn |
| Dec 31, 2024 | 107.48 Mn |
| Dec 31, 2024 | 107.48 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Jun 30, 2024 | 37.56 Mn |
| Jun 30, 2024 | 37.56 Mn |
| Mar 31, 2024 | 147.07 Mn |
| Mar 31, 2024 | 147.07 Mn |
| Dec 31, 2023 | 91.67 Mn |
| Dec 31, 2023 | 91.67 Mn |
| Sep 30, 2023 | 148.75 Mn |
| Sep 30, 2023 | 148.75 Mn |
| Jun 30, 2023 | 153.05 Mn |
| Jun 30, 2023 | 153.05 Mn |
| Mar 31, 2023 | 154.27 Mn |
| Mar 31, 2023 | 154.27 Mn |